(Q40945362)

25 September 2017

1 reference

title

Biologic markers and neurochemical correlates of agitation and psychosis in dementia (English)

1 reference

25 September 2017

1 reference

M Kirby

1

1 reference

25 September 2017

B A Lawlor

series ordinal

2

1 reference

25 September 2017

publication date

1 October 1995

1 reference

Journal of Geriatric Psychiatry and Neurology

25 September 2017

published in

1 reference

25 September 2017

volume

8 Suppl 1

1 reference

25 September 2017

page(s)

S2-7

1 reference

Troublesome and disruptive behaviors in dementia. Relationships to diagnosis and disease severity

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Agitated behaviors in the elderly. II. Preliminary results in the cognitively deteriorated

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Prevalence of mental illness in a community nursing home.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Institutionalization of Alzheimer's disease patients: reducing precipitating factors through family counseling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Selective loss of central cholinergic neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Alzheimer's Disease: A Disorder of Cortical Cholinergic Innervation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Cholinergic approaches to the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Neuropathologic and neurochemical correlates of psychosis in primary dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Predictors of disease course in patients with probable Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Alzheimer's disease and depression: neuropsychological impairment and progression of the illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Suicidal behavior, impulsiveness and serotonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Possible neurotransmitter basis of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Central serotonergic hyperresponsivity in late-onset Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Neurochemical Correlates of Major Depression in Primary Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Norepinephrine and MHPG levels in CSF and plasma in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Plasma 3-Methoxy-4-Hydroxyphenylglycol Changes Associated With Clinical State and Schizophrenic Subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Agitation and postdexamethasone cortisol levels in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Does the dexamethasone suppression test relate to subtypes, factors, symptoms, or severity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Adrenocortical hyperactivity in depression: Effects of agitation, delusions, melancholia, and other illness variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Biochemical substrates in normal aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Computed tomography in the elderly. 2. Senile dementia: diagnosis and functional impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Brain lesions and cognitive function in late-life psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

Cognitive and Neurologic Findings in Subjects With Diffuse White Matter Lucencies on Computed Tomographic Scan (Leuko-Araiosis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

A pilot study of haloperidol treatment of psychosis and behavioral disturbance in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F089198879500800102

10.1177/089198879500800102

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference